Restricted accessResearch articleFirst published online 2014-10
IGF2BP1 Expression in Human Mesenchymal Stem Cells Significantly Affects Their Proliferation and Is Under the Epigenetic Control of TET1/2 Demethylases
Mesenchymal stem cells (MSCs) are a population of cells harboring in many tissues with the ability to differentiate toward many different lineages. Unraveling the molecular profile of MSCs is of great importance due to the fact that these cells are very often used in preclinical and clinical studies. We have previously reported the expression of insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) an oncofetal mRNA-binding protein—in different stem cell types such as bone marrow (BM)-MSC and umbilical cord blood (UCB)-hematopoietic stem cells. Here, we demonstrate that MSCs of adipose tissue, BM, and UC origin have a differential pattern of IGF2BP1 and ten-eleven-translocate 1/2 (TET1/2) expression that could correlate with their proliferation potential. Upon IGF2BP1 interference, a significant reduction of cell proliferation is observed, accompanied by reduced expression of c-MYC and GLI1 and increased p21. We also present, for the first time, evidence that IGF2BP1 is epigenetically regulated by TET1 and TET2 demethylases. Specifically, we show that TET1 directly binds to the promoter of IGF2BP1 gene and affects the hydroxymethylation status of its promoter. These results indicate that IGF2BP1 and TET1/2 contribute to the stemness of MSCs, at least regarding their proliferative potential.
Get full access to this article
View all access options for this article.
References
1.
FriedensteinAJ, GorskajaJF and KulaginaNN. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol, 4:267–274.
2.
KernS, EichlerH, StoeveJ, KluterH and BiebackK. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24:1294–1301.
3.
PhinneyDG and ProckopDJ. (2007). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views. Stem Cells, 25:2896–2902.
4.
IoannidisP, MahairaLG, PerezSA, GritzapisAD, SotiropoulouPA, KavalakisGJ, AntsaklisAI, BaxevanisCN and PapamichailM. (2005). CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells. J Biol Chem, 280:20086–20093.
5.
KatsaraO, MahairaLG, IliopoulouEG, MoustakiA, AntsaklisA, LoutradisD, StefanidisK, BaxevanisCN, PapamichailM and PerezSA. (2011). Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev, 20:1549–1561.
6.
BernsteinPL, HerrickDJ, ProkipcakRD and RossJ. (1992). Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev, 6:642–654.
7.
HansenTV, HammerNA, NielsenJ, MadsenM, DalbaeckC, WewerUM, ChristiansenJ and NielsenFC. (2004). Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol, 24:4448–4464.
8.
LemmI and RossJ. (2002). Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol Cell Biol, 22:3959–3969.
9.
NielsenJ, ChristiansenJ, Lykke-AndersenJ, JohnsenAH, WewerUM and NielsenFC. (1999). A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol, 19:1262–1270.
10.
RungeS, NielsenFC, NielsenJ, Lykke-AndersenJ, WewerUM and ChristiansenJ. (2000). H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem, 275:29562–29569.
11.
ChaoJA, PatskovskyY, PatelV, LevyM, AlmoSC and SingerRH. (2010). ZBP1 recognition of beta-actin zipcode induces RNA looping. Genes Dev, 24:148–158.
12.
NoubissiFK, GoswamiS, SanekNA, KawakamiK, MinamotoT, MoserA, GrinblatY and SpiegelmanVS. (2009). Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. Cancer Res, 69:8572–8578.
13.
FengS, JacobsenSE and ReikW. (2010). Epigenetic reprogramming in plant and animal development. Science, 330:622–627.
14.
YannarelliG, PacienzaN, CunibertiL, MedinJ, DaviesJ and KeatingA. (2013). The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells. Stem Cells, 31:215–220.
15.
IyerLM, TahilianiM, RaoA and AravindL. (2009). Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle, 8:1698–1710.
16.
TahilianiM, KohKP, ShenY, PastorWA, BandukwalaH, BrudnoY, AgarwalS, IyerLM, LiuDR, AravindL and RaoA. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324:930–935.
17.
ItoS, D'AlessioAC, TaranovaOV, HongK, SowersLC and ZhangY. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 466:1129–1133.
18.
KohKP, YabuuchiA, RaoS, HuangY, CunniffK, NardoneJ, LaihoA, TahilianiM, SommerCA, et al. (2011). Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell, 8:200–213.
19.
Moran-CrusioK, ReavieL, ShihA, Abdel-WahabO, Ndiaye-LobryD, LobryC, FigueroaME, VasanthakumarA, PatelJ, et al. (2011). Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell, 20:11–24.
20.
KoM, HuangY, JankowskaAM, PapeUJ, TahilianiM, BandukwalaHS, AnJ, LampertiED, KohKP, et al. (2010). Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature, 468:839–843.
21.
SotiropoulouPA, PerezSA, SalagianniM, BaxevanisCN and PapamichailM. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells, 24:462–471.
22.
ZukPA, ZhuM, MizunoH, HuangJ, FutrellJW, KatzAJ, BenhaimP, LorenzHP and HedrickMH. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 7:211–228.
23.
FreudenbergJM, GhoshS, LackfordBL, YellaboinaS, ZhengX, LiR, CuddapahS, WadePA, HuG and JothiR. (2012). Acute depletion of Tet1-dependent 5-hydroxymethylcytosine levels impairs LIF/Stat3 signaling and results in loss of embryonic stem cell identity. Nucleic Acids Res, 40:3364–3377.
24.
ChoudheryMS, BadowskiM, MuiseA and HarrisDT. (2013). Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy, 15:330–343.
25.
DelormeB, RingeJ, PontikoglouC, GaillardJ, LangonneA, SensebeL, NoelD, JorgensenC, HauplT and CharbordP. (2009). Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells, 27:1142–1151.
26.
IoannidisP, MahairaL, PapadopoulouA, TeixeiraMR, HeimS, AndersenJA, EvangelouE, DafniU, PandisN and TrangasT. (2003). CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. Anticancer Res, 23:2179–2183.
27.
WilliamsK, ChristensenJ and HelinK. (2012). DNA methylation: TET proteins-guardians of CpG islands?. EMBO Rep, 13:28–35.
28.
OrbayH, TobitaM and MizunoH. (2012). Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int, 2012:461718
29.
MongrooPS, NoubissiFK, CuatrecasasM, KalabisJ, KingCE, JohnstoneCN, BowserMJ, CastellsA, SpiegelmanVS and RustgiAK. (2011). IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. Cancer Res, 71:2172–2182.
30.
SinghAM and DaltonS. (2009). The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell, 5:141–149.
31.
SatohY, MatsumuraI, TanakaH, EzoeS, SugaharaH, MizukiM, ShibayamaH, IshikoE, IshikoJ, NakajimaK and KanakuraY. (2004). Roles for c-Myc in self-renewal of hematopoietic stem cells. J Biol Chem, 279:24986–24993.
32.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
33.
RobbinsDJ, FeiDL and RioboNA. (2012). The Hedgehog signal transduction network. Sci Signal, 5:re6
34.
MerchantA, JosephG, WangQ, BrennanS and MatsuiW. (2010). Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood, 115:2391–2396.
35.
CostaY, DingJ, TheunissenTW, FaiolaF, HoreTA, ShliahaPV, FidalgoM, SaundersA, LawrenceM, et al. (2013). NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature, 495:370–374.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
